TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Endoscopy results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of complications associated with arterial catheterization
Endpoint domain: Adverse events/effects
Primary endpoint: Mean 7-day pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in serum ferritin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in reticulocyte hemoglobin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in C-reactive protein level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hepatic glycogen levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Seizure recurrence rate
Endpoint domain: Mortality/survival
Primary endpoint: Montgomery-Asberg Depression Scale (MADRS) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of patients with visual gain ≥ 3 ETDRS lines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Toxicity during the treatment period
Endpoint domain: Adverse events/effects
Primary endpoint: Complete and partial response 1 month after the end of therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic extensive GVHD at 1-year
Endpoint domain: Mortality/survival
Primary endpoint: Two-year Event Free Survival (EFS)
Endpoint domain: Mortality/survival
Primary endpoint: Incident atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants With Vaccine Induced Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Reporting Any Non-Serious Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Percent of times that the target definition on planning CT is attained
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of times that the treatment is within the prescription goals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability assessment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Development of AIAs or increase in AIA titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in mean Eczema Area and Severity Index (EASI) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of participants who die
Endpoint domain: Mortality/survival
Primary endpoint: Poor quality of life as assessed by KCCQ
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Patients Maintaining or Improving Their Health Status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: recession depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electromyography (EMG) muscle activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kinematic pattern of movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Signal power of the local field potentials
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of successful evacuation of the uterus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Muscle Sympathetic Activity (MSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baroreflex reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Face, Legs, Activity, Cry and Consolability Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric Mean Titre (GMT) of Varicella Zoster Virus (VZV) Antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric Mean Fold Rise (GMFR) in VZV Antibody Titre
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Patients With Severe Toxicities During the Study Treatment Period
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Patients With Severe Toxicities During the Follow-up Period
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Patients With the Best Overall Response in the Overall Population
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects in remission or with significant reduction in CDAI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Colonic folate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Composition of serum and aortic valve sterols
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Drop in MMSE score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Response to Treatment: Follow up of FVIII, VWF:Ag and VWF:RCo
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of patients with bleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: Graded Wolf Motor Function Test (WMFT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time reaction (TR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recruitment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: adherence to the exercise intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: attrition rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: safety / adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: patient experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of Participants Reporting Product-related Adverse Events (AEs) and Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Participants With a Positive BV Diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Reduced Pain
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Reduced Stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduced Fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Reduced Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduced Insomnia
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Time to complete egg tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Specific Functional Scale Scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean maximal nerve conduction velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: non progression rate after 12 weeks of treatment
Endpoint domain: Mortality/survival
Primary endpoint: Cure or Failure of Urogenital Gonorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: toxic death or relevant grade 4 toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Total Ear Hearing Slope
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of preventive services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Detection of Ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Dose Escalation Index at Day 15 (+/- 3 Days)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Snoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Patient Health Questionnaire (PHQ) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Retention of maxillary fixed prosthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: maternal BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: level of oxytocin in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Rate of ACP Behaviors
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Proportion of Measures Adhered To in the PD Guidelines
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Perception of treatment received
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change scores of the pressure algometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short Form Survey (SF-36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Beck Depression Scale (BDS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to any mood episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prostate Specific Antigen (PSA) Progression-Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: infant pulmonary function test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percent Change in PASI Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: safety of transimmunization treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Complete Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Static 2-point discrimination test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perineal laceration severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pain intensity at Time 0
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain intensity at Time 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain intensity at Time 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Brain Activity (fMRI) as Assessed by Variance in BOLD Signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in Brain Connectivity (fMRI) as Assessed by Pearson's Correlation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: subclinical organ dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in percentage of neutrophils in sputum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Lifetime physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lifestyle factors
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in Body Mass Index z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Clutter Image Rating Scale (CIRS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Life Skills Profile (LSP) - Self-Care Subscale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Goal Attainment Scaling (GAS)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Global motor development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global cognitive development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual and hearing impediments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Infarct Size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Degree of Late Ventricular Remodeling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Left Ventricle Diastolic Dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: adherence to oral chemotherapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Modified Ashworth Scale of the ankle joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in neuromechanical uncoupling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of acute respiratory tract infections
Endpoint domain: Adverse events/effects
Primary endpoint: Major Limb Amputation Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Percent change in serum triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fentanyl consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Clinical improvement based on the 7-point scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: feasibility of CV for identifying GIM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in bowel symptom scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Absence of neurological impairment detected during standard neurological examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mini-mental state score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Absence of cerebral abnormalities detected with PET
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Active Knee Range of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Maximum Voluntary Isometric Contraction (MVIC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Established atherosclerosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical Dementia Rating-Sum of Boxes (CDR-SB)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: First Dose HPV Vaccine Uptake
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Kaplan-Meier Probability of No Disease or Progression at 1 Year
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of Overall Responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-treatment Pain Intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: requirement for ICU treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Left Ventricular End Systolic Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sexual Initiation
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Tolerability of oral topical anesthetic
Endpoint domain: Adverse events/effects
Primary endpoint: Safety Composite
Endpoint domain: Adverse events/effects
Primary endpoint: Severe Solicited Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Total Fatty Acids by Weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Gestational Age
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Birth Length
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Study Enrollment Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percent of STN Visualization Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of DBS Lead Location in Proximity to STN
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Effectiveness of medication review
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hydronephrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Beverage hydration index (BHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intracranial Hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Exclusion of the Left Atrial Appendage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Caries development in enamel and dentine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-month disease control rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score at the SF-12 scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Delivery success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Aneurysm exclusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Pain On Movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of ovarian malignancy
Endpoint domain: Mortality/survival
Primary endpoint: PEG tube device longevity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Detection of sentinel lymph nodes by gamma camera
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of clinically relevant postoperative pancreatic fistula (POPF)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of loose/watery stools
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Apnoea-hypopnea index (AHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time of NIV use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: NIV compliance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Angiographic assessment of neovasculogenesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Major adverse event (death, target limb amputation)
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy of non-invasive endoscopic techniques
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Length of meibomian glands
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area of meibomian glands
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of meibomian glands
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DPREMB-R Scale Mean Total Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline hemoglobin A1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: In-stent luminal late loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Recent HIV Testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Condom Use with Clients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Contraceptive Prevalence Rate
Endpoint domain: Life impact
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Knowledge of overall breast cancer risk
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge of breast density
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change From Baseline in the Six Minute Walk Test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Mean Daily Non-sedentary Daytime Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Natural evolution of lung nodules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Quality of Life in the urinary domain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Complete remission after induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 100% clearance of all AK Lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Occlusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Unprotected vaginal or anal sex occasions
Endpoint domain: Adverse events/effects
Primary endpoint: Overall Survival (12-month Rate)
Endpoint domain: Mortality/survival
Primary endpoint: Prevalence of Fusobacterium necrophorum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Experience of breast cancer
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage decrease of sputum eosinophils
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean back pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Asthenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thoracic disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurological disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes